Recently, Journal of Biomedical Nanotechnology of the American Scientific Publisher announced that Dr.Qian Zhiyong served as the new editor-in-chief. Dr.Qian is the winner of The National Science Fund for Distinguished Young Scholars, and the professor of the State Key Laboratory of Biotherapy of West China Hospital, Sichuan University. Previously, Dr.Qian was the Asian editor of this journal.
Journal of Biomedical Nanotechnology, founded in 2005, is a comprehensive journal of the American Scientific Publisher, with the impact factor of 3.929. It is aimed at becoming the top journal in the biomedical nanotechnology field, and the published papers of this journal are cutting-edge research results in relevant field. The journal provides broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences. The editorial board of the Journal of Biomedical Nanotechnology is composed of Editor-in-Chief, Asian Editor, Associate Editors and Editorial Board. All of them are experts in biomedicine or related fields. The members of the editorial board ensure the forewardness of the research results published in the journal with their professional academic knowledge.
Dr.Qian is the director, professor and doctoral tutor of Biomaterial and Targeted Drug Delivery Research Lab of State Key Laboratory of Biotherapy,West China Hospital, Sichuan University. He is also the winner of The National Science Fund for Distinguished Young Scholars(2012) and The National Science Fund for Outstanding Young Teachers in University(2015). He plays an important part in the Innovative Talents Promotion Program of the Ministry of Science and Technology of the PRC(2016), and he is the key convenor of the 863 Program of the Ministry of Science and Technology of the PRC in the 11th Five-year Plan period, the invited member of Science and Technology Committee of Sichuan CPPCC, and the leader of science and technology in Sichuan province. He is among the 11th batch of the leaders of science and technology in Sichuan province, and among the 1st batch of the leading talents of the Health and Family Planning Commision in Sichuan province. While serving as the editor-in-chief of the Journal of Biomedical Nanotechnology, Dr.Qian is also the executive vice editor of Chinese Chemical Letters (SCI journal, IF = 1.947) and the member of other international academic journals’ editorial board,for instance, Human Gene Therapy (SCI journal, IF = 4.062), Journal of Biological Engineering (SCI journal, IF = 3.0).
Since joining the State Key Laboratory of Biotherapy of West China Hospital,Sichuan University, Dr.Qian mainly engaged in the construction of nano-biomaterials and researches in tumor therapy and tissue repair. Currently, Dr.Qian has published more than 100 SCI papers as the corresponding author or co-corresponding author in some international academic journals such as Chem Soc Review, Adv Mater, ACS Nano, Biomaterials, Theranostics, NPG Asia Materials.His papers were quoted more than 2000 times by Nature Materials, Chem Review, Science Translational Medicine such academic journals with global fame. Besides, he has declared 17 Chinese invention patents, 15 patents of which have been authorized, and his two patented technology products, taxane nanoparticle formulations and PLEL thermosensitive hydrogel preparation, have reached transfer agreements with enterprises.
Related Link: http://www.aspbs.com/jbn.html